Latest Anesthetic Stories
Administration of the commonly used stimulant drug methylphenidate (Ritalin) was able to speed recovery from general anesthesia in an animal study conducted at Massachusetts General Hospital (MGH).
Anesthesiology researchers have shown that a device approved by the Food and Drug Administration to reduce the risk that patients will recall their surgery does not lower the risk of the problem, known as intraoperative awareness, any more than a less expensive method.
While some pain killers need to be injected into the damaged tissue in order to work, topical anaesthetics only need to be spread on the surface.
Updated ASA Standard Requires Capnography During Procedural Sedation Cases Oridion heralds capnography monitoring requirement for procedures involving moderate or deep sedation Jerusalem, Israel/Needham, MA (PRWEB) July 20, 2011 Oridion Systems Ltd.
PARSIPPANY, N.J., May 23, 2011 /PRNewswire/ -- Pacira Pharmaceuticals, Inc., (Nasdaq: PCRX), an emerging specialty pharmaceutical company, today announced that clinical data highlighting the safety profile of EXPAREL(TM) (bupivacaine extended-release liposome injection) will be presented at the 2011 International Anesthesia Research Society (IARS) Annual Meeting in Vancouver, British Columbia.
PARSIPPANY, N.J., May 5, 2011 /PRNewswire/ -- Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX), an emerging specialty pharmaceutical company, today announced that clinical and preclinical data highlighting the safety and efficacy of EXPAREL(TM) will be presented at two medical meetings.
WASHINGTON, March 30, 2011 /PRNewswire-USNewswire/ -- Following is the daily "Profile America" feature from the U.S. Census Bureau: (Logo: http://photos.prnewswire.com/prnh/20090226/CENSUSLOGO) WEDNESDAY, MARCH 30: A SURGICAL BREAKTHROUGH Profile America -- Wednesday, March 30th.
SAN DIEGO, March 18, 2011 /PRNewswire/ -- Novalar Pharmaceuticals, Inc., a dental specialty pharmaceutical company, today announced that they have entered into an agreement with Septodont for the acquisition of OraVerseÂ®, Novalar's first-in-class local anesthesia reversal agent.
FORT COLLINS, Colo., March 7, 2011 /PRNewswire/ -- St. Renatus, LLC, the northern Colorado start-up Company dedicated to bringing to market a needle-free dental anesthetic, announced today that the company had a favorable End of Phase 2 review with the U.S.
Chile collaboration is bringing surgical patients closer to having a long-acting local anesthetic.
- A transitional zone between two communities containing the characteristic species of each.